AnodyneWiki

Disable conformers
Collapse all
Light theme

Methylhexanamine

Read
1,3-DMAA
Methylhexanamine
Molecular structure via molpic based on CDK
[]
Conformer structure via 3Dmol.js
Enable javascript to view conformer structure via 3Dmol.js
Physical properties
[]
115.22 g/mol [1]
Density0.7655 g/cu cm at 20 °C g/cm3 [1]
AppearanceLiquid [1]
OdorAmine odor [1]
Boiling point132.5 °C [1]
SolubilitySlightly soluble in water; very soluble in ethanol, ether, chloroform and dilute acid [1]
1.9 [1]
Structural Identifiers
[]
C7H17N [1]
4-methylhexan-2-amine [1]
CCC(C)CC(C)N [1]
InChI=1S/C7H17N/c1-4-6(2)5-7(3)8/h6-7H,4-5,8H2,1-3H3 [1]
InChIKeyYAHRDLICUYEDAU-UHFFFAOYSA-N [1]
Pharmacokinetics[]
Elimination half-life~8.5 hours

Methylhexanamine (also known as 1,3-Dimethylamylamine, 1,3-Dimethylpentylamine, Methylhexaneamine, Forthane, 2-Amino-4-methylhexane, 4-Methyl-2-hexanamine, Forthan, 4-Methyl-2-hexylamine, Dimethylamylamine or Geranamine)

Chemistry

 []

Methylhexanamine is a racemic mixture of the .

(2S,5S)-MethylhexanamineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(2R,5S)-MethylhexanamineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(2S,5R)-MethylhexanamineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(2R,5R)-MethylhexanamineGenerated by the Chemistry Development Kit (http://github.com/cdk)
Stereoisomer enumberation with rdkit

Subjective effects []

class / Stimulant

Experience reports []

There are currently 3 experience reports involving methylhexanamine on :

 []

  • Australia: Methylhexanamine is a S10 substance.
  • Brazil: Methylhexanamine is a F2 substance.[3]
  • United States: Methylhexanamine is a Unapproved drug; use in dietary supplements, food, or medicine is unlawful.{-{Efn|The N.D.A (New Drug Application) for methylhexanamine was withdrawn in 1983. Consequently, any product containing methylhexanamine cannot be marketed in the United States until a new application is approved.|group=note}-} substance.[4][5][6][7]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 7753, 1,3-Dimethylamylamine. Accessed May 5, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/7753

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methylhexanamine. UNII: X49C572YQO. Global Substance Registration System. Accessed May 5, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/X49C572YQO

  3. Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed May 5, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451

  4. DMAA: A prohibited stimulant. DoD. October 12, 2022. Accessed May 5, 2026. https://www.opss.org/article/dmaa-prohibited-stimulant

  5. DMAA in Products Marketed as Dietary Supplements. February 22, 2023. Accessed May 5, 2026. https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/dmaa-products-marketed-dietary-supplements?ref=smartchoicelist.com

  6. United States v. Hi-Tech Pharmaceuticals, Inc., No. 17-13376 (11th Cir. 2019). August 30, 2019. Accessed May 5, 2026. https://law.justia.com/cases/federal/appellate-courts/ca11/17-13376/17-13376-2019-08-30.html

  7. Meyer H. E. R. Squibb & Sons, inc. et al.; Withdrawal of Approval of New Drug Applications. Food and Drug Administration. November 9, 1983. Accessed May 5, 2026. https://www.govinfo.gov/content/pkg/FR-1983-11-09/pdf/FR-1983-11-09.pdf